Wall Street’s Key Stock Analysts Research Report, All Buys

Wall Street’s Key Stock Analysts Research Report, All Buys

#buys #bullish #WallStreet #analysts

$CRSP $NEO $TMUS $TSCO

These are all Buys if you can manage the risk.

Daily HeffX-LTN reviews dozens of Wall Street’s Key analysts research reports to ID new trading and investing ideas for HeffX-LTN readers. These reports cover stocks to buy

Below is our list for Thursday, 30 July, as follows:

CRISPR Therapeutics A.G. (NASDAQ:CRSP): Chardan reiterated its Buy, and raised its target price to 100 from 72.50, and Needham reiterated its Buy rating and raised its target to 105 from 84.

NeoGenomics Inc. (NASDAQ:NEO) was reiterated as Buy and its price target was raised to 39 from 33 at Needham.

T-Mobile US Inc. (NASDAQ:TMUS) was started as Buy with a 140 target price at Deutsche Bank.

Tractor Supply Co. (NASDAQ:TSCO): This rural retailer just had its best Quarter in its history. Shares closed Wednesday at 145.46 and have a consensus price target at 154.18.

Have a healthy day, Keep the Faith!

The following two tabs change content below.

Paul Ebeling

Paul A. Ebeling, a polymath, excels, in diverse fields of knowledge Including Pattern Recognition Analysis in Equities, Commodities and Foreign Exchange, and he it the author of "The Red Roadmaster's Technical Report on the US Major Market Indices, a highly regarded, weekly financial market commentary. He is a philosopher, issuing insights on a wide range of subjects to over a million cohorts. An international audience of opinion makers, business leaders, and global organizations recognize Ebeling as an expert.